Raymond James Financial
MDWD icon

Raymond James Financial’s MediWound MDWD Stock Holding History

Raymond James Financial’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-318
Closed -$6.16K – 6003
2025
Q2 		$6.16K Buy
+318
New +$5.99K ﹤0.01% 6099

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial's MDWD Position: Q3 2025 in Review

Raymond James Financial sold out of MediWound (MDWD) in Q3 2025, closing a stake of 318 shares — an estimated $6.16K sold.

Raymond James Financial first reported a position in MDWD in Q2 2025 and held it in 1 quarter. The position peaked at $6.16K in Q2 2025. 76 funds tracked by Wall St. Rank hold MDWD as of Q3 2025.

  • Raymond James Financial reported no remaining MediWound position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 318 MediWound shares in Q3 2025, an estimated $6.16K.
  • Raymond James Financial first reported a position in MediWound in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's MediWound position peaked at $6.16K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.